Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 744-753 of 2362


Study Shows Third Gene as Indicator for Breast Cancerby Nicholas BakalarThe New York TimesAugust 6th, 2014Mutations in the gene raise risk in women by almost as much as mutations in BRCA1 and BRCA2, the genes implicated in most inherited cases.
Data Yearning to Become Expensive Informationby Pete ShanksBiopolitical TimesAugust 6th, 2014Big players have big “big data and genetics” plans afoot. Here’s the news from Genomics England, 23andMe, Google and Craig Venter.
Use of Experimental Ebola Drug Raises Red Flags Among Medical Expertsby Monte MorinLos Angeles TimesAugust 5th, 2014The FDA has authorized use of an unapproved Ebola virus test under a special emergency-use provision, although efforts to develop a vaccine for the deadly illness are unlikely to bear fruit until 2015.
Genetic Testing of Citizens: A Backdoor Into Total Population Surveillance by Governments, Companiesby Helen WallaceEpoch TimesAugust 3rd, 2014The new Chief Executive of England's National Health Service wants to make people’s personal genetic information the basis of their treatments.
Banks of Blood and Spermby Rebecca J. RosenThe AtlanticJuly 31st, 2014Banking on the Body investigates how the idea of a "bank" shapes the way we think about storing and distributing blood, sperm, and breast milk.
F.D.A. Acts on Lab Tests Developed In-Houseby Andrew PollackThe New York TimesJuly 31st, 2014The FDA will start regulating medical laboratory testing, saying that tests used to make important treatment decisions must be vetted before they go into use.
Google Wants to Create a Map of What a Healthy Human Body Looks Likeby George Dvorskyio9July 25th, 2014Called the Baseline Project, it's different from other mass medical and genomic projects in that it's seeking to collect much larger and broader sets of new data.
Making Sense of the BRAINby Jessica CussinsBiopolitical TimesJuly 24th, 2014As criticisms of the brain projects on both sides of the Atlantic ramp up, what lessons can be learned from the successes and failures of the Human Genome Project?
Failures and Risks in Biosafety Regulationby Pete ShanksBiopolitical TimesJuly 24th, 2014Accidents at CDC and elsewhere point up the difficulties in regulating potentially dangerous releases of genetically modified organisms, which scientists are, quite responsibly, discussing.
Proposed Gene Technology Could Alter Organisms in Wildby Carolyn Y. JohnsonBoston GlobeJuly 17th, 2014Scientists say that this use of the new gene-editing technology could lead to inadvertent species extinctions, new genes spreading through the environment in unexpected ways, and unforeseen ecological ripple effects.
Displaying 744-753 of 2362  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760